Catecholamine-synthesizing enzymes in carcinoid tumors and pheochromocytomas

Clinical Chemistry

Volumn 49, Issue 4, 2003, Pages 586-593

  Meijer, Wim G ^a   Copray, Sjef C V M ^a   Hollema, Harry ^a   Kema, Ido P ^a   Zwart, Nynke ^a   Mantingh Otter, Ietje ^a   Links, Thera P ^a   Willemse, Pax H B ^a   De Vries, Elisabeth G E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AVIDIN; BIOTIN; DOPAMINE BETA MONOOXYGENASE; PARAFFIN; PEROXIDASE; PHENYLETHANOLAMINE N METHYLTRANSFERASE; TYROSINE 3 MONOOXYGENASE;

ARTICLE; CARCINOID; CATECHOLAMINE SYNTHESIS; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME SPECIFICITY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; METABOLIC REGULATION; PHEOCHROMOCYTOMA; PROTEIN EXPRESSION; SEROTONIN RELEASE; SIPPLE SYNDROME; URINARY EXCRETION;

ADRENAL GLAND NEOPLASMS; ADULT; CARCINOID TUMOR; CATECHOLAMINES; DOPAMINE BETA-HYDROXYLASE; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PHENYLETHANOLAMINE N-METHYLTRANSFERASE; PHEOCHROMOCYTOMA; SEROTONIN; TYROSINE 3-MONOOXYGENASE;

EID: 0037379951     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/49.4.586     Document Type: Article

References (28)

1. Pearse AGE. The APUD cell concept and its implications in pathology. In: Sommers SC, ed. Pathology annual. New York: Appleton Century Crofts, 1974:27-41.
2. DeLillis RA, Tischler AS, Wolfe HJ. Multidirectional differentiation in neuroendocrine neoplasms. J Histochem Cytochem 1984;32:899-904.
3. Lehnert H. Regulation of catecholamine synthesizing enzyme gene expression in human pheochromocytoma. Eur J Endocrinol 1998;138:363-7.
4. Tumer N, Brown JW, Carballeira A, Fishman LM. Tyrosine hydroxylase gene expression in varying forms of human pheochromocytoma. Life Sci 1996;59:1659-65.
5. Funahashi H, Imai T, Tanaka Y, Tobinaga J, Wada M, Matsuyama T, et al. Discrepancy between PNMT presence and relative lack of adrenaline production in extra-adrenal pheochromocytoma. J Surg Oncol 1994;57:196-200.
6. Iwase K, Nagasaka A, Nagatsu I, Kiuchi K, Nagatsu T, Funahashi H, et al. Tyrosine hydroxylase indicates cell differentiation of catecholamine biosynthesis in neuroendocrine tumors. J Endocrinol Invest 1994;17:235-9.
7. Lloyd RV, Sisson JC, Shapiro B, Verhofstad AAJ. Immunohistochemical localization of epinephrine, norepinephrine, catecholamine synthesizing enzymes, and chromogranin in neuroendocrine cells and tumors. Am J Pathol 1986;125:45-54.
8. Isobe K, Nakai T, Yukimasa N, Nanmoku T, Takekoshi K, Nomura F. Expression of mRNA coding for four catecholamine-synthesizing enzymes in human adrenal pheochromocytomas. Eur J Endocrinol 1998;138:383-7.
9. Tormey WP, FitzGerald RJ. The clinical and laboratory correlates of an increased urinary 5-hydroxyindoleacetic acid. Postgrad Med J 1995;71:542-5.
10. Williams ED, Sandler M. The classification of carcinoid tumours. Lancet 1963;i:238-9.
11. Moertel CG. An Odyssey in the land of small tumors. J Clin Oncol. 1987;5:1503-22.
12. Norheim I, Öberg K, Theodorsson-Norheim E, Lindgren PG, Lundqvist G, Magnussen A, et al. Malignant carcinoid tumors: an analysis of 103 patients with regard to tumor localization, hormone production and survival. Ann Surg 1987;206:115-25.
13. Tyce GM. Biochemistry of serotonin. In: VanHoutte PM, ed. Serotonin and the cardiovascular system. New York: Raven Press, 1985:1-13.
14. Kema IP, de Vries EGE, Slooff MJH, Biesma B, Muskiet FAJ. Serotonin, catecholamines, histamine and their metabolites in urine, platelets and tumor tissue of patients with carcinoid tumors. Clin Chem 1994;40:86-95.
15. Feldman JM. Increased dopamine production in patients with carcinoid tumours. Metabolism 1985;34:255-60.
16. Kema IP, Schellings AMJ, Meiborg G, Hoppenbrouwers CJM, Muskiet FAJ. Influence of a serotonin- and dopamine-rich diet on platelet serotonin content and urinary excretion of biogenic amines and their metabolites. Clin Chem 1992;38:1730-6.
17. Kema IP, Meiborg G, Nagel GT, Stob GJ, Muskiet FAJ. Isotope dilution ammonia chemical ionization mass fragmentographic analysis of urinary 3-O-methylated catecholamine metabolites. Rapid sample clean-up by derivatization and extraction of lyophilized samples. J Chromatogr Biomed Appl 1993;671:181-9.
18. Kema IP, Schellings AMJ, Hoppenbrouwers CJM, Rutgers HM, de Vries EGE, Muskiet FAJ. High performance liquid chromatographic profiling of tryptophan and related indoles in body fluids and tissues of carcinoid patients. Clin Chim Acta 1993;221:143-58.
19. Ahlman H, McRae A, Jansson S, Mölne J, Dahlström A. Immunocytochemical and biochemical evidence of catecholamine secretion from human midgut carcinoid tumour cells in culture. Biogenic Amines 1990;7:399-408.
20. Wängberg B, Ahlman H, Nilsson O, Haglid K, Denney RM, Dahlström A. Amine handling properties of human carcinoid tumour cells in tissue culture. Neurochem Int 1990;17:331-41.
21. Gilbert JA, Bates LA, Ames MM. Elevated aromatic-L-amino acid decarboxylase in human carcinoid tumors. Biochem Pharmacol 1995;50:845-50.
22. Gazdar AF, Helman LJ, Israel MA, Russell EK, Linnoila I, Mulshine JL, et al. Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin. Cancer Res 1988;48:4078-82.
23. Vos MD, Scott FM, Iwai N, Treston AM. Expression in human lung cancer cell lines of genes of prohormone processing and the neuroendocrine phenotype. J Cell Biochem Suppl 1996;24:257-68.
24. Eisenhofer G, Walther MM, Huynh TT, Li ST, Bornstein SR, Vortmeyer A, et al. Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. J Clin Endocrinol Metab 2001;86:1999-2008.
25. Nilsson O, Dahlström A, Tisell LE, Ahlman H. Growth of human pheochromocytomas in the anterior eye-chambre of the rat. A histochemical study of amine and peptide content of pheochromocytoma tumour cells. Regul Peptides 1986;15:129-41.
26. Matuchansky C, Launay JM. Serotonin, catecholamines, and spontaneous midgut carcinoid flush: plasma studies from flushing and nonflushing sites. Gastroenterology 1995;108:743-51.
27. Hoffmann J, Grimm W, Menz V, Wied M, Sprenger A, Arnold R, et al. Prognostic value of heart rate variability analysis in patients with carcinoid syndrome. Digestion 2001;63:35-42.
28. Meijer WG, van Veldhuisen DJ, Kema IP, van den Berg MP, Boomsma F, Willemse PHB, et al. Cardiovascular abnormalities in patients with a carcinoid syndrome. Neth J Med 2002;60:10-6.